[Overwiew of compounding oncology pharmacy in France in 2021]

Ann Pharm Fr. 2024 Jun;82(4):618-628. doi: 10.1016/j.pharma.2024.02.004. Epub 2024 Feb 8.
[Article in French]

Abstract

The pharmacotechnical expert group of the French Society of Oncological Pharmacy presents the results of its national survey carried out in 2021 in the form of an inventory of pharmaceutical compounding units dedicated to oncology. Premises, equipment, controls, production flows and trends are described in this article, providing an overview of the sector at a time when the new Good Manufacturing Practices (GMP) are applicable. This overview will allow us to better address the needs and expectations of production pharmacists regarding the application of GMP and the development of their units.

Keywords: Chemotherapy; Chimiothérapie; Oncologie; Oncology; Pharmaceutical compounding; Pharmaceutical production; Pharmaceutical technology; Pharmacotechnie; Production pharmaceutique; Préparations.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Antineoplastic Agents
  • Drug Compounding* / standards
  • France
  • Humans
  • Medical Oncology
  • Neoplasms / drug therapy
  • Pharmacies
  • Pharmacists

Substances

  • Antineoplastic Agents